Top Markets
#1 MiL.k Alliance MiL.k Alliance +34.49%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.30%
#3 Biconomy Biconomy +20.08%
#4 Glidr Glidr +19.56%
#5 THORChain THORChain +18.25%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +15.96%
#7 Moolah Moolah +14.63%
#8 Tokamak Network Tokamak Network +14.19%
#9 THORChain Yield THORChain Yield +13.55%
#10 Tutorial Tutorial +12.80%
Coin of the day
MiL.k Alliance MiL.k Alliance
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Kedudukan dalam Saham #4854
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Harga Saham
$3.55
Modal Pasaran
$3.27B
Perubahan (1 hari)
2.68%
Perubahan (1 tahun)
-50.04%
Negara
CN
Perdagangan Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Kategori

Healthcare
Nisbah P/B bagi Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Hebei Changshan Biochemical Pharmaceutical Co., Ltd., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Hebei Changshan Biochemical Pharmaceutical Co., Ltd. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH